Replies to post #112288 on Biotech Values

[marthambles]

Looks like Sandoz/MNTA may need to turn down production volumes to keep mLov closer to a 50% market share.

Would raising the price be an option to reduce market share?

[dewophile]

i think the idea is to capture 50% market share by revenue, which at 14% discount to branded would be 55% or so by volume

also bear in mind hosptial and outpt Rx may not track perfectly, and outpt pricing a bit higher than hospital so margins a bit better so if you're going to take a bt more market share somewhere you want to take it in the outpt segment

i think they (mnta/sandoz) knows what they are doing and are wary of sparking a price war